Stem cell treatment for recent brain bleeding
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether giving stem cells shortly after a brain bleed can help recovery. It aims to see if the treatment is safe and may improve healing and function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You had a brain bleed confirmed by a CT scan, and it's been 3 to 10 days since it started.
- The bleed is in a certain size range (15-30 mL) and not needing surgery to remove it.
- You must be able to have blood tests, scans, and follow-up visits as scheduled.
- You are not pregnant or breastfeeding, and you agree to use contraception if needed.
- You have not had a previous stroke with lasting symptoms, or recent seizures, or serious infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who have had a brain bleed (intracerebral hemorrhage) to learn more about their recovery over time. It does not involve a new treatment but rather follows participants to understand the condition better.
This trial looks at how people recover after surgery for a brain bleed (intracerebral hemorrhage). It aims to find the best timing for treatment to improve recovery. If you have had a brain bleed and are eligible for surgery, you may be able to join.
This trial tests a non-invasive ultrasound device to help clear blood clots from the brain after a spontaneous bleed. It may be an option for people with small to medium-sized bleeds who do not need surgery.
This study tests a drug called Cerebrolysin, which may help protect the brain after a bleeding stroke. It is given within 6 hours of the stroke, and researchers will check if it is safe and helps improve recovery.
This study tests whether a treatment made from donor stem cells (called mesenchymal stromal cells) can help people recover from a severe traumatic brain injury. The cells are given through a vein within 48 hours of the injury.
This trial tests whether a single infusion of stem cells from donated umbilical cord tissue can help calm inflammation in the brain after severe traumatic brain injury. It is for patients aged 18–50 who need brain pressure monitoring and are not responding to verbal commands 5 days after sedation is stopped.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.